Search results for #VKTX
Insider transaction alert: Mancini Marianna sells over 280,000 shares of Viking Therapeutics, Inc. for $22.1M. #VKTX #insidertrading $VKTX sharkstracker.com/insiders/VKTX
@mistressdivy In the main portfolio it is still #SMCI (up over 100%) even after meaningful correction. In the risky portfolio it is #VKTX
$LTRN sube 15%. Creo está junto con $VKTX y $OSCR hay que tenerlas en cuenta en su campo. Ya avisé de #VKTX en el mes de enero.
$VKTX Nash data due any day #BOSSTrading #VKTX
#vktx güne dususle basladi. Iki gun once duseni kirdi ama kendine yeni bir direnc olusturdu . 80.25 ustune atarsa tekrar mutlu edecegini umuyorum. 75.40 asagisi biraz üzebilir . Ytd ..
@PocketsAbyss Agree. $LLY is now a $700 billion company with a killer obesity franchise. $PFE is $145 billion with -0-. For $15 billion they could buy their way into the hottest and fastest growing market. #VKTX
Check out my #VKTX analysis on @tradingview: tradingview.com/x/b3czNDco/
🔥 Viking Therapeutics leads the way in the obesity market with a focus on what truly matters: efficacy AND safety. $VKTX excels where others falter. And the TA setup looks sweet. #Biotech #Healthcare #VKTX 💥👌
#vktx şubat ayinda 38 dolardan 90 dolarlara sicramis. Bugün düşeni kırmayı denedi . Kirması halinde değerlendirilebilir . Ytd
Pre-market Rant --> optionmillionaires.com/jb-pre-market-… 🎬0:22 #markets $SPY $SPX 🎬2:25 $VKTX #VKTX #glp1 🎬3:12 $RILY #rily 🎬5:09 $TRUP #trupanion 🎬6:22 $PYPL #paypal 🎬6:45 $SQ #sq 🎬7:26 $CDLX #cardytics 🎬8:06 $CAVA #CAVA 🎬8:20 #AI $AI $NVDA
@haodongvli ALL big pharma needs to be in the obesity business. $PFE needs to wake up and use some of their market cap to become relevant again. #VKTX . With $1B net cash, they don't need money or partners. Only a buyout will do at this point, so pay $150 now or $250 later.
3 Millionaire-Maker Biotech Stocks (#IOVA, $IOVA, #RXRX, $RXRX, #VKTX, $VKTX, #biotechstocks) The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential. fool.com/investing/2024…